Astrana Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
February 27, 2024 at 04:05 pm EST
Share
Astrana Health, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 353.04 million compared to USD 294.21 million a year ago. Net income was USD 12.36 million compared to net loss of USD 3.73 million a year ago. Basic earnings per share from continuing operations was USD 0.26 compared to basic loss per share from continuing operations of USD 0.08 a year ago. Diluted earnings per share from continuing operations was USD 0.26 compared to diluted loss per share from continuing operations of USD 0.08 a year ago.
For the full year, revenue was USD 1,386.66 million compared to USD 1,144.16 million a year ago. Net income was USD 60.72 million compared to USD 45.17 million a year ago. Basic earnings per share from continuing operations was USD 1.3 compared to USD 1 a year ago. Diluted earnings per share from continuing operations was USD 1.29 compared to USD 0.99 a year ago.
Astrana Health, Inc. is a healthcare company. The Company provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's Care Enablement segment is an integrated, end-to-end clinical and administrative platform, powered by its technology suite, which provides operational, clinical, financial, technology, management, and strategic services. Its Care Partners segment is focused on building and managing provider networks by partnering with provider partners for coordinated care delivery. Its Care Delivery segment is a data-driven care delivery organization focused on delivering accessible care to all patients. Its care delivery organization includes primary care, multi-specialty care, and ancillary care services.